LeadIQ logo
Learn more at LeadIQ.com

Insights

Clinical Studies for SCO-101 Scandion Oncology's lead compound, SCO-101, is currently in clinical phase I and II studies, indicating a potential upcoming commercialization opportunity for sales engagement.

Market Gap for Drug Resistant Cancer Addressing the challenge of drug-resistant cancer diseases, Scandion Oncology aims to provide innovative solutions, showcasing a market gap that sales teams can leverage for growth.

Expansion of Drug Pipeline With several preclinical programs aiming to broaden their drug pipeline, Scandion Oncology presents future opportunities for partnerships and sales as new products enter development stages.

Competitive Analysis in Biotech By analyzing similar companies like Tiziana Life Sciences and Allarity Therapeutics, a sales strategy focusing on differentiation and unique value propositions can be devised to compete effectively in the biotech industry.

Revenue and Funding Context Understanding Scandion Oncology's revenue and funding range provides insights for sales professionals to tailor offerings that align with the financial scale of the company, optimizing sales strategies accordingly.

Similar companies to Scandion Oncology

Scandion Oncology Tech Stack

Scandion Oncology uses 8 technology products and services including MySQL, Twitter Emoji (Twemoji), Highstock, and more. Explore Scandion Oncology's tech stack below.

  • MySQL
    Database
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Highstock
    Javascript Graphics
  • jQuery Migrate
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players
  • Apache HTTP Server
    Web Servers

Media & News

Scandion Oncology's Email Address Formats

Scandion Oncology uses at least 1 format(s):
Scandion Oncology Email FormatsExamplePercentage
FL@scandiononcology.comJD@scandiononcology.com
50%
FL@scandiononcology.comJD@scandiononcology.com
50%

Frequently Asked Questions

Where is Scandion Oncology's headquarters located?

Minus sign iconPlus sign icon
Scandion Oncology's main headquarters is located at Fruebjergvej 3 Copenhagen, DK 2100 DK. The company has employees across 3 continents, including EuropeNorth AmericaOceania.

What is Scandion Oncology's official website and social media links?

Minus sign iconPlus sign icon
Scandion Oncology's official website is scandiononcology.com and has social profiles on LinkedIn.

How much revenue does Scandion Oncology generate?

Minus sign iconPlus sign icon
As of August 2024, Scandion Oncology's annual revenue reached $750K.

What is Scandion Oncology's SIC code NAICS code?

Minus sign iconPlus sign icon
Scandion Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Scandion Oncology have currently?

Minus sign iconPlus sign icon
As of August 2024, Scandion Oncology has approximately 8 employees across 3 continents, including EuropeNorth AmericaOceania. Key team members include Ceo: F. R. M.Cso And Co-Founder Of Scandion Oncology: J. S.Executive Vice President & Cfo: J. S.. Explore Scandion Oncology's employee directory with LeadIQ.

What industry does Scandion Oncology belong to?

Minus sign iconPlus sign icon
Scandion Oncology operates in the Biotechnology Research industry.

What technology does Scandion Oncology use?

Minus sign iconPlus sign icon
Scandion Oncology's tech stack includes MySQLTwitter Emoji (Twemoji)HighstockjQuery MigrateYoast SEOGoogle Tag ManagerYouTubeApache HTTP Server.

What is Scandion Oncology's email format?

Minus sign iconPlus sign icon
Scandion Oncology's email format typically follows the pattern of . Find more Scandion Oncology email formats with LeadIQ.

How much funding has Scandion Oncology raised to date?

Minus sign iconPlus sign icon
As of August 2024, Scandion Oncology has raised $902K in funding. The last funding round occurred on Jun 22, 2020 for $902K.

When was Scandion Oncology founded?

Minus sign iconPlus sign icon
Scandion Oncology was founded in 2017.
Scandion Oncology

Scandion Oncology

Biotechnology ResearchDK, Denmark2-10 Employees

Scandion Oncology A/S is a listed Danish biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. The company's first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. 
The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases.

Section iconCompany Overview

Headquarters
Fruebjergvej 3 Copenhagen, DK 2100 DK
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
2-10

Section iconFunding & Financials

  • $902K

    Scandion Oncology has raised a total of $902K of funding over 3 rounds. Their latest funding round was raised on Jun 22, 2020 in the amount of $902K.

  • $10M

    Scandion Oncology's revenue is in the range of $10M

Section iconFunding & Financials

  • $902K

    Scandion Oncology has raised a total of $902K of funding over 3 rounds. Their latest funding round was raised on Jun 22, 2020 in the amount of $902K.

  • $10M

    Scandion Oncology's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.